• View the talks
• 36 min
  1. Streptococcus pneumoniae: serotype diversity and epidemiology

  • Dr. Bambos Charalambous
• 38 min
  2. Tuberculosis: new treatments in evolution

  • Prof. Stephen Gillespie
• 55 min
  3. Current drugs for TB treatment

  • Dr. Kasha Singh
• 41 min
  4. Global progress in TB vaccine development

  • Prof. Helen McShane
• 34 min
  5. Management of MDR and XDR TB

  • Prof. Martin Boeree
• 61 min
  6. Non-tuberculous mycobacterial pulmonary disease (NTM-PD)

  • Prof. Jakko van Ingen
• 51 min
  7. The making of an influenza pandemic

  • Prof. Jonathan Van-Tam
• 51 min
  8. Responding to pandemic influenza

  • Prof. Jonathan Van-Tam
  • Dr. Chloe Sellwood
• 38 min
  9. Controlling pandemic flu

  • Prof. John Oxford
• 30 min
  10. The future of influenza vaccines

  • Dr. Marc P. Girard
• 29 min
  11. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide

  • Dr. Marietjie Venter
  • Mrs. Orienka Hellferscee
• 34 min
  12. RSV vaccine development

  • Prof. Ruth Karron
• 32 min
  13. Respiratory mycoplasmas

  • Prof. Stephen Gillespie
• 52 min
  14. Infection in the cystic fibrosis lung

  • Dr. Stuart Elborn
• 34 min
  15. The role of infection at COPD exacerbations

  • Prof. Wisia Wedzicha
• 58 min
  16. An overview of non-cystic fibrosis bronchiectasis

  • Dr. Maeve P. Smith
• 27 min
  17. Legionella: epidemiology and human infection, environment and diagnosis

  • Dr. Diane Lindsay
• 24 min
  18. Pathogen discovery in the respiratory tract

  • Dr. H. Rogier van Doorn
• 38 min
  19. Aspergillosis infections and the lung

  • Prof. Rosemary Barnes
• 23 min
  20. Parasitic lung infections: protozoa, cestodes & trematodes

  • Dr. Vannan Kandi Vijayan
• 16 min
  21. Parasitic lung infections: nematodes

  • Dr. Vannan Kandi Vijayan
• 37 min
  22. Improving respiratory diagnostics (viruses)

  • Prof. David Murdoch

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Talk outline
3. The power of infection
4. No man is an island
5. Why did some survived, while others died?
6. Obama's message
7. Three levels of protection
8. Britain 3 sources of defense - navy
9. Britain 3 sources of defense - air force
10. Britain 3 sources of defense - home front
11. The influenza virus
12. The influenza vaccine
13. Anti-viral drugs
14. The three faces of hygiene
15. 2009 swine flu outbreak
16. 2009 outbreak - underlying health problems
17. Flu pandemics - years of life lost
18. Bird flu - what has that got to do with us?
19. Bird flu outbreak - from birds to humans
20. The common cold clinic
21. Retroscreen virology
22. The perfect volunteer
23. Common cold unit in action
24. Common cold unit - results
25. Influenza specific protein responses - baseline
26. Pre-existing T cells limit disease
27. Influenza virus components
28. British army in France, 1918
29. The beginning of 1918 flu pandemic
30. Researching the new virus on the front
31. What’s needed for an influenza virus to emerge?
32. Chemical warfare as a predisposing factor
33. Vera Brittain - a nurse on the front
34. Researching the 1918 virus
35. Virus beaters
36. Pandemic BBC television program
37. Influenza case (1)
38. Lead coffin
39. Influenza case (2)
40. Search for samples (1)
41. Search for samples (2)
42. Search for samples (3)
43. Digging graves (1)
44. Digging graves (2)
45. The pandemic window of 1918
46. New aspects into modern science
47. Concluding remarks

Topics Covered

• The power of infection
• Three levels of protection
• The influenza virus
• The influenza vaccine
• Anti-viral drugs
• The three faces of hygiene
• 2009 swine flu outbreak
• Flu pandemics
• years of life lost
• Bird flu
• The common cold clinic – influenza research in Retroscreen virology
• Influenza virus components
• The 1918 flu pandemic
• Researching the new virus on the front
• What’s needed for an influenza virus to emerge?
• Researching the 1918 virus
• The pandemic window of 1918
• New aspects into modern science

Links

Series:

• Respiratory Infection

Categories:

• Clinical Practice
• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Publication History

• Published on December 1, 2013

Financial Disclosures

• Prof. John Oxford has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.